We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LNTH market cap is 6.92B. The company's latest EPS is USD 4.5628 and P/E is 22.17.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 354M | 369.98M | 394.09M | 378.73M | 391.11M |
| Operating Income | 137.49M | 100.38M | 102.73M | 133.74M | 111.71M |
| Net Income | 103.38M | 131.07M | 62.07M | 131.09M | -11.79M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 339.41M | 425.21M | 935.06M | 1.3B | 1.53B |
| Operating Income | -4.2M | -76.09M | 36.2M | 364.64M | 448.56M |
| Net Income | -13.47M | -71.28M | 28.07M | 326.66M | 312.44M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.65B | 1.83B | 1.94B | 2.05B | 1.98B |
| Total Liabilities | 835.26M | 885.79M | 913.15M | 869.92M | 892.33M |
| Total Equity | 815.89M | 945.54M | 1.03B | 1.18B | 1.09B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 869.82M | 863.78M | 1.32B | 1.65B | 1.98B |
| Total Liabilities | 355.62M | 399.35M | 874.11M | 835.26M | 892.33M |
| Total Equity | 514.21M | 464.44M | 447.15M | 815.89M | 1.09B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 305.26M | 127.24M | 211.96M | 387.02M | 544.75M |
| Investing | 5.94M | -106.53M | -151.62M | -219.41M | -226.02M |
| Financing | -13.06M | -16.85M | -16.75M | -14.88M | -118.54M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.4M | 53.92M | 281.78M | 305.26M | 544.75M |
| Investing | -4.91M | 3.68M | -276.55M | 5.94M | -226.02M |
| Financing | -21.86M | -39.33M | 311.69M | -13.06M | -118.54M |
| Market Cap | 6.92B |
| Price to Earnings Ratio | 22.17 |
| Price to Sales Ratio | 4.52 |
| Price to Cash Ratio | 7.59 |
| Price to Book Ratio | 6.37 |
| Dividend Yield | - |
| Shares Outstanding | 68.48M |
| Average Volume (1 week) | 1.24M |
| Average Volume (1 Month) | 1.17M |
| 52 Week Change | 68.58% |
| 52 Week High | 126.8899 |
| 52 Week Low | 56.44 |
| Spread (Intraday) | 3.4 (3.35%) |
| Company Name | Lantheus Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lantheus.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
